Laurus Labs signed pact with Global Fund to supply ARV drugs
Pharma Laurus Labs of Hyderabad has signed an agreement with Global Fund, an organization working towards ending AIDS, tuberculosis and malaria as epidemics, for a period of three-and-a-half years. This agreement has a motive to supply Anti retro viral (ARV) combination medicine namely Tenofovir/ Lamivudine/ Dolutegravir of 300/300/50mg (TLD) in Sub Saharan African (SSA) region for treating HIV/AIDS in sub-Saharan Africa. Laurus Labs will have volume commitments from the Global Fund to increase the access for the HIV/AIDS treatment by meeting the unmet needs and helping people.
Centre issues guidelines to set up health infra in rural areas
The Government of India recently issued guidelines to contain COVID-19 in rural areas. ContentsWhat ...
Integrated Health Information Platform: Key Facts
The Union Health Minister Dr Harsh Vardhan recently launched the Integrated Health Information Platf...
National Pharmacy Week celebrated in India
The Indian Pharmaceutical Association in collaboration with Delhi Pharmaceutical Trust celebrated th...
November 17: National Epilepsy Day
Every year, the National Epilepsy Day is celebrated on November 17. The day is celebrated to create ...
GoI releases “Health in India” report
The Ministry of Statistics and Programme Implementation recently released a report titled “Health ...
|View All E-Books: Recent Release|